Literature DB >> 12468544

The Coxsackievirus and adenovirus receptor (CAR) forms a complex with the PDZ domain-containing protein ligand-of-numb protein-X (LNX).

Kerstin Sollerbrant1, Elisabeth Raschperger, Momina Mirza, Ulla Engstrom, Lennart Philipson, Per O Ljungdahl, Ralf F Pettersson.   

Abstract

The Coxsackievirus and adenovirus receptor (CAR) functions as a virus receptor, but its primary biological function is unknown. A yeast two-hybrid screen was used to identify Ligand-of-Numb protein-X (LNX) as a binding partner to the intracellular tail of CAR. LNX harbors several protein-protein interacting domains, including four PDZ domains, and was previously shown to bind to and regulate the expression level of the cell-fate determinant Numb. CAR was able to bind LNX both in vivo and in vitro. Efficient binding to LNX required not only the consensus PDZ domain binding motif in the C terminus of CAR but also upstream sequences. The CAR binding region in LNX was mapped to the second PDZ domain. CAR and LNX were also shown to colocalize in vivo in mammalian cells. We speculate that CAR and LNX are part of a larger protein complex that might have important functions at discrete subcellular localizations in the cell.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12468544     DOI: 10.1074/jbc.M205927200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  33 in total

1.  Cytokine-mediated downregulation of coxsackievirus-adenovirus receptor in endothelial cells.

Authors:  Theresa Vincent; Ralf F Pettersson; Ronald G Crystal; Philip L Leopold
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

2.  Np9 protein of human endogenous retrovirus K interacts with ligand of numb protein X.

Authors:  Vivienne Armbruester; Marlies Sauter; Klaus Roemer; Barbara Best; Steffen Hahn; Achille Nty; Andreas Schmid; Stephan Philipp; Anja Mueller; Nikolaus Mueller-Lantzsch
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

3.  Adenovirus transduction: More complicated than receptor expression.

Authors:  Priyanka Sharma; Prithy C Martis; Katherine J D A Excoffon
Journal:  Virology       Date:  2016-12-31       Impact factor: 3.616

4.  LNX (Ligand of Numb-protein X) interacts with RhoC, both of which regulate AP-1-mediated transcriptional activation.

Authors:  Dan Zheng; Yaqiong Sun; Shaohua Gu; Chaoneng Ji; Wei Zhao; Yi Xie; Yumin Mao
Journal:  Mol Biol Rep       Date:  2009-08-23       Impact factor: 2.316

5.  1. Alternative splicing of viral receptors: A review of the diverse morphologies and physiologies of adenoviral receptors.

Authors:  Katherine J D A Excoffon; Jonathan R Bowers; Priyanka Sharma
Journal:  Recent Res Dev Virol       Date:  2014

6.  Coxsackie-adenovirus receptor as a novel marker of stem cells in treatment-resistant non-small cell lung cancer.

Authors:  Xiaochun Zhang; Bingliang Fang; Radhe Mohan; Joe Y Chang
Journal:  Radiother Oncol       Date:  2012-09-27       Impact factor: 6.280

7.  Organizer restriction through modulation of Bozozok stability by the E3 ubiquitin ligase Lnx-like.

Authors:  Hyunju Ro; Igor B Dawid
Journal:  Nat Cell Biol       Date:  2009-08-09       Impact factor: 28.824

8.  Isoform-specific regulation and localization of the coxsackie and adenovirus receptor in human airway epithelia.

Authors:  Katherine J D A Excoffon; Nicholas D Gansemer; Matthew E Mobily; Philip H Karp; Kalpaj R Parekh; Joseph Zabner
Journal:  PLoS One       Date:  2010-03-26       Impact factor: 3.240

9.  Improved adenovirus type 5 vector-mediated transduction of resistant cells by piggybacking on coxsackie B-adenovirus receptor-pseudotyped baculovirus.

Authors:  Ophélia Granio; Marine Porcherot; Stéphanie Corjon; Kuntida Kitidee; Petra Henning; Assia Eljaafari; Andrea Cimarelli; Leif Lindholm; Pierre Miossec; Pierre Boulanger; Saw-See Hong
Journal:  J Virol       Date:  2009-04-08       Impact factor: 5.103

10.  Loss of the coxsackie and adenovirus receptor contributes to gastric cancer progression.

Authors:  M Anders; M Vieth; C Röcken; M Ebert; M Pross; S Gretschel; P M Schlag; B Wiedenmann; W Kemmner; M Höcker
Journal:  Br J Cancer       Date:  2009-01-13       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.